The market for coagulation factor deficiency treatments is experiencing robust growth, driven by advancements in biotechnology and the increasing prevalence of bleeding disorders. Innovations in therapeutic options and improved patient access to healthcare contribute to the expanding…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.